EUVIMEDEUVIMED entdecken
Crossref

A Granzyme B-Cleavable T Cell-Targeted Bispecific Cell Vesicle Connector for Reversing New-Onset Type 1 Diabetes

Yanfang Wang, Yanping Sun, Xiuwen Zhang, Shenqiang Wang, Xuehui Huang, Kairui Xu, Yun Liu, Yingqi Huang, Jianchang Xu iD, Xinwei Wei, Hao Cheng iD, Liqiang Pan und 2 weitere

Journal of the American Chemical Society · 2025

DOI: 10.1021/jacs.4c13644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2025. Verfasst von Yanfang Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Granzymes, CD8-Positive T-Lymphocytes, Antibodies, Bispecific. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: JDRF, Zhejiang University, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1GranzymesCD8-Positive T-LymphocytesAntibodies, BispecificAnimalsMiceHumansMice, Inbred NODInterleukin-2

Substanzen

GranzymesInterleukin-2Antibodies, Bispecific

Autor:innen und Institutionen

  • State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • Jinhua Institute of Zhejiang University, Jinhua 321299, China.
  • Department of Materials Science and Engineering, Drexel University, Philadelphia, Pennsylvania 19104, United States.
  • Key Laboratory of Advanced Drug Delivery Systems of Zhejiang Province, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310009, China.
  • Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China.

ORCID-Profile: Jianchang Xu, Hao Cheng, Zhen Gu

Förderung

  • JDRF
  • Zhejiang University
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Key Project of Science and Technology Commission of Zhejiang Province

Zitieren

APA

Wang, Y., Sun, Y., Zhang, X., Wang, S., Huang, X., Xu, K., Liu, Y., Huang, Y., Xu, J., Wei, X., Cheng, H., Pan, L., Wang, J., & Gu, Z. (2025). A Granzyme B-Cleavable T Cell-Targeted Bispecific Cell Vesicle Connector for Reversing New-Onset Type 1 Diabetes. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.4c13644

Vancouver

Wang Y, Sun Y, Zhang X, Wang S, Huang X, Xu K, et al. A Granzyme B-Cleavable T Cell-Targeted Bispecific Cell Vesicle Connector for Reversing New-Onset Type 1 Diabetes. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.4c13644

BibTeX
@article{Wang2025,
  author = {Wang, Yanfang and Sun, Yanping and Zhang, Xiuwen and Wang, Shenqiang and Huang, Xuehui and Xu, Kairui and Liu, Yun and Huang, Yingqi and Xu, Jianchang and Wei, Xinwei and Cheng, Hao and Pan, Liqiang and Wang, Jinqiang and Gu, Zhen},
  title = {A Granzyme B-Cleavable T Cell-Targeted Bispecific Cell Vesicle Connector for Reversing New-Onset Type 1 Diabetes},
  journal = {Journal of the American Chemical Society},
  year = {2025},
  doi = {10.1021/jacs.4c13644}
}
Kostenlos starten →